Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Lifetime Management of Aortic Stenosis with Dr Samineh Sehatbakhsh
Author(s): Samineh Sehatbakhsh Added: 8 months ago
Explore comprehensive lifetime management strategies for aortic stenosis with Dr Samineh Sehatbakhsh, addressing the evolving landscape of treatment options for patients across all risk categories.This detailed presentation, part of the Complex Cases track, examines the critical decision-making process between TAVR and surgical aortic valve replacement in the modern era. Dr Sehatbakhsh addresses… View more

Intervention
APSC Position Statement on TAVI for Aortic Stenosis
Author(s): Jonathan Yap , Kentaro Hayashida , Michael Kang-Yin Lee , et al Added: 1 year ago

Intervention
TCT 24: The TAVR UNLOAD Trial
Author(s): Nicolas M Van Mieghem Added: 1 year ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter aortic valve replacement (TAVR) in addition to optimal heart failure therapy (OHFT) compared to OHFT alone in patients with heart failure and moderate aortic stenosis.Dr Nicolas M Van Mieghem (Erasmus University Medical Center, Rotterdam, NL) joins us onsite at TCT Conference to discuss the findings from TAVR UNLOAD (NCT02661451)… View more

Intervention
LV Health Does Not Alter Early TAVR Benefit in Aortic Stenosis
Added: 2 months ago Source:  Radcliffe Cardiology
An exploratory analysis of the EARLY TAVR trial has found that the benefits of early transcatheter aortic valve replacement (TAVR) for asymptomatic severe aortic stenosis (AS) are consistent, regardless of baseline left ventricular (LV) health.¹ This suggests that waiting for LV deterioration may not be the optimal strategy for timing intervention.MethodologyThis analysis used data from the EARLY… View more

Imaging & Diagnostics

Intervention
ACCURATE Neo2 in Rheumatic Aortic Stenosis
Author(s): Ivan Wong , Michael Chiang , Angus Shing Fung Chui , et al Added: 1 year ago

Intervention

Vascular Disease and Surgery
EuroPCR 25: LANDMARK 1Y Outcomes
Author(s): Patrick W Serruys Added: 11 months ago
EuroPCR 25 - Novel Myval THV shows non-inferiority at one year compared to established valves in severe aortic stenosis.We are joined by Dr Patrick Serruys (Erasmus University Medical Center, Rotterdam, NL) to discuss key findings from the LANDMARK trial.This multinational, multicentric, randomized controlled trial compared the safety and effectiveness of the Myval THV Series against contemporary… View more

Intervention

Vascular Disease and Surgery
CRT 25: Insights from the GUARD Study
Author(s): Baravan Al-Kassou Added: 1 year ago
CRT 25 - Insights on the progression risk in patients with mild to moderate aortic stenosis (AS) show that there was no significant difference in progression rates between mild and moderate AS. However, moderate AS patients had significantly higher mortality rates than mild AS patients at one- and two-year follow ups. The study also suggests that elevated phosphate levels and elevated… View more

Vascular Disease and Surgery
TCT 24: The EVOLVED Trial
Author(s): Marc Dweck Added: 1 year ago
TCT Conference 2024 - Clinical outcomes of early intervention in patients with asymptomatic aortic stenosis (AS) did not impact the composite primary outcome of all cause mortality and unplanned AS related hospitalisation.Dr Marc Dweck (University of Edinburgh, Edinburgh, UK) joins us in this short interview filmed onsite at TCT Conference to discuss the findings from EVOLVED (NCT03094143;… View more

Imaging & Diagnostics

Intervention
First Philippine Valve-in-valve TAVR In a Trifecta Aortic Bioprosthesis
Author(s): Jowana Lyn S Pagulayan-Rivas , Marc Louie Del Rosario , Ofelia Valencia , et al Added: 1 month ago

Imaging & Diagnostics

Intervention
TCT 24: Pooled Analysis of RHEIA and PARTNER 3
Author(s): Didier Tchétché Added: 1 year ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter aortic valve replacement (TAVR) compared to surgical aortic valve replacement (SAVR) in female patients with severe aortic stenosis.Dr Didier Tchétché (Clinique Pasteur, FR) joins us onsite at TCT Conference to discuss the pooled findings from the RHEIA (NCT04160130) and PARTNER 3 (NCT02675114) trials.RHEIA and PARTNER 3 are… View more

Demographic

Intervention